Production (Stage)
Pulmonx Corporation
LUNG
$3.11
-$0.01-0.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.16% | 16.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.16% | 16.57% | |||
| Cost of Revenue | 0.34% | 15.18% | |||
| Gross Profit | -7.09% | 17.06% | |||
| SG&A Expenses | -3.17% | 6.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.22% | 7.72% | |||
| Operating Income | -8.54% | 5.04% | |||
| Income Before Tax | -8.95% | 5.84% | |||
| Income Tax Expenses | 255.26% | -80.21% | |||
| Earnings from Continuing Operations | -9.66% | 6.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.66% | 6.85% | |||
| EBIT | -8.54% | 5.04% | |||
| EBITDA | -8.85% | 4.42% | |||
| EPS Basic | -8.62% | 7.55% | |||
| Normalized Basic EPS | -7.96% | 6.58% | |||
| EPS Diluted | -8.62% | 7.55% | |||
| Normalized Diluted EPS | -7.96% | 6.58% | |||
| Average Basic Shares Outstanding | 0.94% | 0.78% | |||
| Average Diluted Shares Outstanding | 0.94% | 0.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||